Dostarlimab plus chemotherapy followed by dostarlimab plus niraparib maintenance therapy among patients with primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial

Mansoor Mirza, Sharad Ghamande, Lars Hanker, Destin Black, Nicoline Raascou-Jensen, Lucy Gilbert, Ana Oaknin, Angeles Alvarez Secord, Antonella Savarese, Robert G. Holloway, Rebecca Kristeleit, Joseph Buscema, Ingrid Boere, Sudarshan Sharma, Christine Gennigens, Prafull Ghatage, Kaitlin Yablonski, Shadi Stevens, Hanna Trukhan, Matthew A. Powell